INDP
Price:
$0.9092
Market Cap:
$10.92M
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.[Read more]
Industry
Biotechnology
IPO Date
2015-08-04
Stock Exchange
NASDAQ
Ticker
INDP
According to Indaptus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.65M. This represents a change of -47.21% compared to the average of 6.91M of the last 4 quarters.
The mean historical Enterprise Value of Indaptus Therapeutics, Inc. over the last ten years is 174.44M. The current 3.65M Enterprise Value has changed 109.26% with respect to the historical average. Over the past ten years (40 quarters), INDP's Enterprise Value was at its highest in in the December 2021 quarter at 23.28B. The Enterprise Value was at its lowest in in the September 2021 quarter at -9121996.48.
Average
174.44M
Median
13.46M
Minimum
-15646423.70
Maximum
1.44B
Discovering the peaks and valleys of Indaptus Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 421.75%
Maximum Annual Enterprise Value = 1.44B
Minimum Annual Increase = -408.51%
Minimum Annual Enterprise Value = -15646423.70
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.60M | -34.31% |
2022 | 2.43M | -115.55% |
2021 | -15646423.70 | -408.51% |
2020 | 5.07M | -43.26% |
2019 | 8.94M | -95.44% |
2018 | 195.95M | 421.75% |
2017 | 37.56M | -23.07% |
2016 | 48.82M | 171.46% |
2015 | 17.98M | -98.75% |
2014 | 1.44B | 12.38% |
The current Enterprise Value of Indaptus Therapeutics, Inc. (INDP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-3871299.05
5-year avg
479.34K
10-year avg
174.44M
Indaptus Therapeutics, Inc.’s Enterprise Value is less than Rezolute, Inc. (247.14M), less than Tempest Therapeutics, Inc. (33.01M), greater than Comera Life Sciences Holdings, Inc. (-1590126.00), less than Forte Biosciences, Inc. (12.44M), less than ABVC BioPharma, Inc. (8.81M), greater than Pasithea Therapeutics Corp. (-6092141.00), less than Better Therapeutics, Inc. (7.71M), less than Nutriband Inc. (37.65M), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), less than Longeveron Inc. (4.93M), less than RenovoRx, Inc. (21.40M), less than Virax Biolabs Group Limited (4.10M), less than Blue Water Vaccines, Inc. (12.48M), greater than Revelation Biosciences, Inc. (-4029924.00), greater than Hillstream BioPharma, Inc. (1.48M), less than Kiora Pharmaceuticals, Inc. (4.31M), less than Anebulo Pharmaceuticals, Inc. (40.61M), less than ZIVO Bioscience, Inc. (78.24M), greater than Metacrine, Inc. (-62299000.00), less than Assembly Biosciences, Inc. (66.55M),
Company | Enterprise Value | Market cap |
---|---|---|
247.14M | $255.53M | |
33.01M | $37.39M | |
-1590126.00 | $6.15K | |
12.44M | $28.80M | |
8.81M | $6.62M | |
-6092141.00 | $3.27M | |
7.71M | $5.45K | |
37.65M | $43.21M | |
-667131.00 | $2.45M | |
4.93M | $26.11M | |
21.40M | $30.96M | |
4.10M | $7.47M | |
12.48M | $3.41M | |
-4029924.00 | $2.51M | |
1.48M | $4.17M | |
4.31M | $9.87M | |
40.61M | $42.01M | |
78.24M | $78.37M | |
-62299000.00 | $0 | |
66.55M | $93.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indaptus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Indaptus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Indaptus Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Indaptus Therapeutics, Inc. (INDP)?
What is the 3-year average Enterprise Value for Indaptus Therapeutics, Inc. (INDP)?
What is the 5-year average Enterprise Value for Indaptus Therapeutics, Inc. (INDP)?
How does the current Enterprise Value for Indaptus Therapeutics, Inc. (INDP) compare to its historical average?